Dukoral Efficacy for Cholera and E. coli

Efficacy Against Cholera

Dukoral demonstrates approximately 85% efficacy against cholera at 6 months post-immunization, with effectiveness varying by population studied 1, 2
Efficacy reaches ~85% at 6 months after completing the two-dose series, administered 1-6 weeks apart, providing robust short-term protection 1, 2, 3
Duration of protection varies considerably between individuals, lasting up to 3 years in some cases, with the vaccine containing killed whole-cell Vibrio cholerae O1 and purified recombinant B subunit of cholera toxin 1, 4, 5
The vaccine is the only internationally available cholera vaccine, licensed in approximately 20 countries, and provides reliable protection for travelers to areas with active cholera transmission 1

For cholera-endemic areas, Dukoral provides reliable protection and should be considered for travelers, with primary prevention through safe water, food precautions, and sanitation remaining the cornerstone of cholera control 1, 2, 3, 6
The World Health Organization recommends considering Dukoral for travelers to areas with active cholera transmission, with the Centers for Disease Control and Prevention also recommending primary prevention through safe water, food precautions, and sanitation 1, 6

The Centers for Disease Control and Prevention recommends avoiding food and drink for 1 hour before and after vaccine administration, as standard practice for oral vaccines 7
The World Health Organization suggests separating the Dukoral vaccine from the yellow fever vaccine by at least 3 weeks if possible, as simultaneous administration decreases antibody response to both vaccines 8, 7, 9

The Centers for Disease Control and Prevention advises that the Dukoral vaccine can be administered simultaneously with measles, BCG, or hepatitis B vaccines 9

The American Society of Tropical Medicine and Hygiene recommends the Dukoral vaccine for adults 18-64 years traveling to cholera-affected areas, with the World Health Organization considering it for travelers to areas with active cholera transmission 10
The Centers for Disease Control and Prevention notes that the Dukoral vaccine is not required for entry into the United States from cholera-affected areas, and no country currently requires it for entry 10